Toxicity and efficacy of chronomodulated chemotherapy: a systematic review
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Toxicity and efficacy of chronomodulated chemotherapy: a systematic review
Authors
Keywords
-
Journal
LANCET ONCOLOGY
Volume 23, Issue 3, Pages e129-e143
Publisher
Elsevier BV
Online
2022-03-01
DOI
10.1016/s1470-2045(21)00639-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clocks, cancer, and chronochemotherapy
- (2021) Aziz Sancar et al. SCIENCE
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- Optimizing circadian drug infusion schedules towards personalized cancer chronotherapy
- (2020) Roger J. W. Hill et al. PLoS Computational Biology
- Phase I pharmacological study of continuous chronomodulated capecitabine treatment
- (2020) Jeroen Roosendaal et al. PHARMACEUTICAL RESEARCH
- Sex‐dependent least toxic timing of irinotecan combined with chronomodulated chemotherapy for metastatic colorectal cancer: Randomized multicenter EORTC 05011 trial
- (2020) Pasquale F. Innominato et al. Cancer Medicine
- Diurnal transcriptome atlas of a primate across major neural and peripheral tissues
- (2018) Ludovic S. Mure et al. SCIENCE
- Circadian rhythms and the kidney
- (2018) Dmitri Firsov et al. Nature Reviews Nephrology
- Neonatal rat cardiomyocytes as an in vitro model for circadian rhythms in the heart
- (2017) Bastiaan C. du Pré et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Systems Chronotherapeutics
- (2017) Annabelle Ballesta et al. PHARMACOLOGICAL REVIEWS
- Pronounced between-subject and circadian variability in thymidylate synthase and dihydropyrimidine dehydrogenase enzyme activity in human volunteers
- (2016) Bart A. W. Jacobs et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cisplatin-based chronotherapy for advanced non-small cell lung cancer patients: a randomized controlled study and its pharmacokinetics analysis
- (2015) Jie Li et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Daily rhythms are retained both in spontaneously developed sarcomas and in xenografts grown in immunocompromised SCID mice
- (2014) Maria Comas et al. CHRONOBIOLOGY INTERNATIONAL
- Colorectal liver metastases with a disrupted circadian rhythm phase shift the peripheral clock in liver and kidney
- (2014) Sander A. Huisman et al. INTERNATIONAL JOURNAL OF CANCER
- Circadian variability of pharmacokinetics of cisplatin in patients with non-small-cell lung carcinoma: analysis with the NONMEM program
- (2013) Rong Chen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Sex differences in circadian timing systems: Implications for disease
- (2013) Matthew Bailey et al. FRONTIERS IN NEUROENDOCRINOLOGY
- Randomized study of sinusoidal chronomodulated versus flat intermittent induction chemotherapy with cisplatin and 5-fluorouracil followed by traditional radiotherapy for locoregionally advanced nasopharyngeal carcinoma
- (2013) Huan-Xin Lin et al. Chinese Journal of Cancer
- Sex moderates circadian chemotherapy effects on survival of patients with metastatic colorectal cancer: a meta-analysis
- (2012) S. Giacchetti et al. ANNALS OF ONCOLOGY
- Chronochimiothérapie à base de 5-fluorouracil, acide folinique et oxaliplatine administrée en deux jours toutes les deux semaines pour le cancer colorectal. L’expérience du CHC-Liège (Belgique)
- (2012) C. Focan et al. PATHOLOGIE BIOLOGIE
- A randomized study comparing short-time infusion of oxaliplatin in combination with capecitabine XELOX30 and chronomodulated XELOX30 as first-line therapy in patients with advanced colorectal cancer
- (2009) C. Qvortrup et al. ANNALS OF ONCOLOGY
- Circadian variation in intestinal dihydropyrimidine dehydrogenase (DPD) expression: A potential mechanism for benefits of 5FU chrono-chemotherapy
- (2009) Kamran Abolmaali et al. SURGERY
- A Randomized Multicenter Study of Optimal Circadian Time of Vinorelbine Combined with Chronomodulated 5‐Fluorouracil in Pretreated Metastatic Breast Cancer Patients: EORTC Trial 05971
- (2008) Bruno Coudert et al. CHRONOBIOLOGY INTERNATIONAL
- A Four-Arm, Randomized, Multicenter Phase II Trial of Oxaliplatin Combined with Varying Schedules of 5-Fluorouracil as First-line Therapy in Previously Untreated Advanced Colorectal Cancer
- (2008) Ramesh K. Ramanathan et al. Clinical Colorectal Cancer
- The influence of circadian rhythms on the kinetics of drugs in humans
- (2008) Massimo Baraldo Expert Opinion on Drug Metabolism & Toxicology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started